CLINICAL_TRIALS
research
· 2017-06-20
Clinical Trial Update: The Effect of Alemtuzumab on the Blood-brain-barrier and the Brain's Metabolism in Multiple Sclerosis Patients
Summary
A clinical trial entry investigates the effect of alemtuzumab on the blood-brain barrier and brain metabolism in patients with multiple sclerosis. The current t…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Multiple Sclerosis | Status: UNKNOWN